FDA Approves Adcetris® in Combination with Chemotherapy for Previously Untreated Stage III or IV Classical Hodgkin Lymphoma

(March 22, 2018)

CancerConnect News: The U.S. Food and Drug Administration (FDA) has approved Adcetris (brentuximab vedotin) in combination with chemotherapy in adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma. The approval is based... Continue Reading


Addition of the Precision Cancer Medicine Adcetris Reduces the Risk of Treatment Failure in Advanced Hodgkin Lymphoma

(March 1, 2018)

CancerConnect News: Patients with advanced Hodgkin lymphoma (HL) who were treated with a multi-drug regimen that included the precision cancer medicine Adcetris (brentuximab vedotin) had a 23-percent reduction in the risk of disease progression, death,... Continue Reading


Latest Hodgkin\'s Lymphoma News By Stage


Advanced Stage Hodgkin's Lymphoma

Sorry, there are no articles available for this cancer stage.

More Advanced Stage Hodgkin's Lymphoma

Early Stage Hodgkin's Lymphoma

Sorry, there are no articles available for this cancer stage.

More Early Stage Hodgkin's Lymphoma

Progressive Relapsed Hodgkin's Lymphoma

Sorry, there are no articles available for this cancer stage.

More Progressive Relapsed Hodgkin's Lymphoma